-
Something wrong with this record ?
Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation
L. Pácal, K. Kuricová, K. Kaňková,
Language English Country United States
Document type Journal Article, Review
Grant support
NT13198
MZ0
CEP Register
NLK
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
PubMed
24936250
DOI
10.4239/wjd.v5.i3.288
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
- Review MeSH
Growing prevalence of diabetes (type 2 as well as type 1) and its related morbidity due to vascular complications creates a large burden on medical care worldwide. Understanding the molecular pathogenesis of chronic micro-, macro- and avascular complications mediated by hyperglycemia is of crucial importance since novel therapeutic targets can be identified and tested. Thiamine (vitamin B1) is an essential cofactor of several enzymes involved in carbohydrate metabolism and published data suggest that thiamine metabolism in diabetes is deficient. This review aims to point out the physiological role of thiamine in metabolism of glucose and amino acids, to present overview of thiamine metabolism and to describe the consequences of thiamine deficiency (either clinically manifest or latent). Furthermore, we want to explain why thiamine demands are increased in diabetes and to summarise data indicating thiamine mishandling in diabetics (by review of the studies mapping the prevalence and the degree of thiamine deficiency in diabetics). Finally, we would like to summarise the evidence for the beneficial effect of thiamine supplementation in progression of hyperglycemia-related pathology and, therefore, to justify its importance in determining the harmful impact of hyperglycemia in diabetes. Based on the data presented it could be concluded that although experimental studies mostly resulted in beneficial effects, clinical studies of appropriate size and duration focusing on the effect of thiamine supplementation/therapy on hard endpoints are missing at present. Moreover, it is not currently clear which mechanisms contribute to the deficient action of thiamine in diabetes most. Experimental studies on the molecular mechanisms of thiamine deficiency in diabetes are critically needed before clear answer to diabetes community could be given.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064287
- 003
- CZ-PrNML
- 005
- 20190826143837.0
- 007
- ta
- 008
- 140704s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4239/wjd.v5.i3.288 $2 doi
- 035 __
- $a (PubMed)24936250
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pácal, Lukáš $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. $7 xx0084072
- 245 10
- $a Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation / $c L. Pácal, K. Kuricová, K. Kaňková,
- 520 9_
- $a Growing prevalence of diabetes (type 2 as well as type 1) and its related morbidity due to vascular complications creates a large burden on medical care worldwide. Understanding the molecular pathogenesis of chronic micro-, macro- and avascular complications mediated by hyperglycemia is of crucial importance since novel therapeutic targets can be identified and tested. Thiamine (vitamin B1) is an essential cofactor of several enzymes involved in carbohydrate metabolism and published data suggest that thiamine metabolism in diabetes is deficient. This review aims to point out the physiological role of thiamine in metabolism of glucose and amino acids, to present overview of thiamine metabolism and to describe the consequences of thiamine deficiency (either clinically manifest or latent). Furthermore, we want to explain why thiamine demands are increased in diabetes and to summarise data indicating thiamine mishandling in diabetics (by review of the studies mapping the prevalence and the degree of thiamine deficiency in diabetics). Finally, we would like to summarise the evidence for the beneficial effect of thiamine supplementation in progression of hyperglycemia-related pathology and, therefore, to justify its importance in determining the harmful impact of hyperglycemia in diabetes. Based on the data presented it could be concluded that although experimental studies mostly resulted in beneficial effects, clinical studies of appropriate size and duration focusing on the effect of thiamine supplementation/therapy on hard endpoints are missing at present. Moreover, it is not currently clear which mechanisms contribute to the deficient action of thiamine in diabetes most. Experimental studies on the molecular mechanisms of thiamine deficiency in diabetes are critically needed before clear answer to diabetes community could be given.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Chalásová, Katarína $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. $7 mub2017949800
- 700 1_
- $a Kaňková, Kateřina, $u Lukáš Pácal, Katarína Kuricová, Kateřina Kaňková, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. $d 1971- $7 mzk2003190820
- 773 0_
- $w MED00176994 $t World journal of diabetes $x 1948-9358 $g Roč. 5, č. 3 (2014), s. 288-295
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24936250 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20190826144056 $b ABA008
- 999 __
- $a ind $b bmc $g 1031771 $s 863019
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 5 $c 3 $d 288-295 $i 1948-9358 $m World journal of diabetes $n World j. diabetes $x MED00176994
- GRA __
- $a NT13198 $p MZ0
- LZP __
- $a Pubmed-20140704